CEO Pascal Soriot said Europe was "falling behind" in attracting investment and needed to "invest more in what really matters ...

AstraZeneca PLC ADR closed 22.59% below its 52-week high of $87.68, which the company achieved on August 30th.

(Reuters) -AstraZeneca has rejoined the main U.S. drug lobby group, roughly two years after leaving it, the Pharmaceutical ...

Today's announcement could potentially add to a string of bad tariff news that has cost Roche 10.9%, Lilly 14%, and AstraZeneca stock 14.4% over the past week. Still, it remains to be seen ...

AstraZeneca is a top healthcare company with a robust pipeline of drugs in development. Uber Technologies has been a growth beast in recent years, and robotaxis could open up a huge opportunity ...

In the latest market close, Astrazeneca (AZN) reached $64.90, with a -1.35% movement compared to the previous day. The stock's change was more than the S&P 500's daily loss of 1.57%. Elsewhere ...

Credit: aslysun / Shutterstock. AstraZeneca recently announced positive toplined interim results from SERENA-6, a randomised, multicentre, double-blind Phase III trial. The trial evaluated the ...

You can even create transparent backgrounds, if needed, or specify colors using hex codes. Other improvements come in the way ChatGPT can accept and remix your own images, and incorporate other ...

Results from the PURSUIT Phase IIb trial for AstraZeneca’s (AZN) AZD0780 demonstrated a statistically significant low-density lipoprotein cholesterol reduction when administered on top of ...

It’s not HBO, it’s Max — but the new standalone logo for Warner Bros. Discovery‘s streamer now certainly looks like HBO’s at a glance. The Max streaming service has quietly launched a ...

Well, scientists have already proven it can be done. And now they’ve developed a new kind of transparent wood that acts like glass but with surprising advantages. Not only is it strong and ...

The PHERGain study was supported by F Hoffmann-La Roche. JMP-G reports consulting roles for Daiichi Sankyo, AstraZeneca, Roche, Gilead, Merck Sharp & Dohme, Eisai, Seattle Genetics, and Lilly; travel ...